Customer Service 1 (888) 261-2693
Please enter Search keyword. Advanced Search

An Upcoming Opportunity You Won't Want to Miss

By Dr. Steve Sjuggerud
Thursday, July 16, 2015

Two weeks ago, I had one of the greatest experiences of my life...
Imagine if you were a golfer and you got to hang out with Jack Nicklaus, Arnold Palmer, and Phil Mickelson for a few days...
Imagine if they gave talks on stage about how to get better at golf – and they were accessible enough offstage that you could get in a few words with them – maybe pulling up a chair next to them at lunch, or catching them for a casual conversation.
I recently did that (though it was a guitar event, not a golf event) – and it was one of the greatest experiences of my life.
I promise you I will bring that spirit to the 2015 Stansberry Conference Series Las Vegas event this October...
This is a Stansberry Research event. And if you've been to one of our events in the last year or two, you know we do it RIGHT.
Last year, our Stansberry Society meetings introduced an average of 400 attendees to an array of fascinating ideas. The goal was to introduce you to big ideas AND the incredible people behind the events that shape our world.
This included people like WikiLeaks founder Julian Assange, Tesla cofounder J.B. Straubel, and my personal favorite, big-wave-surfing legend Laird Hamilton. But this October's event should be even better...
We have assembled a fantastic group of some of the greatest minds in the world, including Stansberry Research founder Porter Stansberry and Congressman Dr. Ron Paul.
Dr. Paul, as you might know, is likely the only honest man to ever serve in the U.S. Congress. He'll give the audience an update on why he believes a major global stock market disaster is on the way.
You'll also meet the man who led the Federal Reserve's 2008 Wall Street bailout – Andrew Huszar. Today, he's a senior fellow at Rutgers Business School, which means he's free to tell us what really happened in Washington, D.C. back in the fall of 2008. You won't believe how much money was wasted and who actually got rich on these bailouts.
You'll also have the chance to hear from and interact with all of Stansberry Research's editors, including me, Dr. David Eifrig, Matt Badiali, and Dan Ferris, to name a few.
For two incredible days, you will enjoy fantastic speakers and brilliant ideas... great food... and action-packed presentations. I promise, you will get tons of great ideas that could change your life.
The whole point of our events is to allow you to interact with interesting people who get as excited as we do about new ideas and experiences.

Further Reading:

"I have been able to get close to many of my heroes – both in business and in my hobbies. There's a secret to doing what I've done. And I'll share it with you..."
"These are rules to live by. And they're not just for beginners. Every investor – experienced or novice – should stick to these rules."

Market Notes


Another sign the biotech bull market is still running: Celgene just reached a new all-time high.
Regular readers know that we consider biotech to be one of the greatest "boom and bust" sectors in the market. With its promise of individualized medicine, cancer cures, and miracle drugs, few sectors capture imaginations and speculative money as well as biotechnology.
As our colleague Steve Sjuggerud says, "If you catch just one biotech bull market in your lifetime, you may never have to work again."
Shares of blue chip Celgene are a good way to gauge the action in biotech. The $105 billion biotech behemoth has been enjoying rising sales growth. Just yesterday, Celgene shares hit a new all-time high. The stock is now up 50%-plus over the past year... and its uptrend is another strong sign for the bull market in biotech.

premium teaser

Recent Articles